Kula Investments »

Revance Therapeutics shares owned by Kula Investments

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Kula Investments from 13F filings

Historical chart of Kula Investments investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Kula Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Kula Investments

Quarter filed Position value Share count Share price at filing
2023-03-31 $1.0M 32k 32.21
2022-12-31 $332k 18k 18.46

More positions owned by Kula Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
W.R. Berkley Corporation (WRB)
General Motors Company (GM)
Western Union Company (WU)
NetApp (NTAP)
Allstate Corporation (ALL)
Hilton Worldwide Holdings (HLT)
ConocoPhillips (COP)
Abbott Laboratories (ABT)
Genuine Parts Company (GPC)
Union Pacific Corporation (UNP)
Marriott Intl Cl A (MAR)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)
Las Vegas Sands (LVS)

View all positions for Kula Investments

Top funds holding Revance Therapeutics

BlackRock
Vanguard Group
Franklin Resources
Fil
Alpine Associates Management
Alliancebernstein
Magnetar Financial
Tang Capital Management
State Street Corporation
Squarepoint Ops
Geode Capital Management
LMR Partners
D. E. Shaw & Co
Qube Research & Technologies
Omni Event Management

View all funds holding Revance Therapeutics